Reuters logo
BRIEF-AstraZeneca says ‍US FDA accepts supplemental biologics license application for Imfinzi
2017年10月17日 / 早上6点18分 / 1 个月前

BRIEF-AstraZeneca says ‍US FDA accepts supplemental biologics license application for Imfinzi

Oct 17 (Reuters) - Astrazeneca Plc

* ‍US FDA ACCEPTS SUPPLEMENTAL BIOLOGICS LICENSE APPLICATION FOR IMFINZI IN LOCALLY ADVANCED UNRESECTABLE NON-SMALL CELL LUNG CANCER​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below